Breaking barriers in stress urinary incontinence care: TAS-303 as a game-changer in pharmacological innovation.

Transl Androl Urol · 2025 · PMC11921414 · PMID 40114827

Europe PMC DOI

hedged sentence

0.8000

closest p · 16.0× alpha

0.8000

boldest claim

The sentences

did not reach statistical significanceP=0.80not close (p > 0.1)

Although a modest increase in maximum urethral closure pressure was observed, the difference between treatment and placebo groups did not reach statistical significance (P=0.80).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.